Iris BioTechnologies Welcomes New Board Member and Key Employees - Seite 2

Gayle Murray has been appointed to the newly created position of Director of Marketing. As Iris prepares for product launch through its subsidiary, Iris Wellness Labs, Gayle will play a key role in both traditional as well as social media marketing. Ms. Murray received her B.A. in Biological Sciences from U. C. Santa Barbara. She is a sales and marketing management professional with 20+ years experience developing and leading major accounts and fundraising programs. She was previously the U. C. Davis Account Executive with J. A. Majors Company, which is the largest medical book distributor in the United States. She managed sales and marketing activities for the University's Medical, Veterinary and Nursing Schools, both in Sacramento and Davis. Gayle is also experienced in industry tradeshows, contract negotiations, promotions, product merchandising, inventory management, customer service, and new employee training.

"Iris is focused on launching personalized precision medical products and services for cancer diagnostics, blood testing, and IVF applications. Having received six patents on our Nano-biochip™ and BioWindows™ Artificial Intelligence System for Genetic Analysis, and with the addition of outstanding people who have a passion for making a difference in helping people through precision medicine, we have positioned ourselves well to offer our solution to the World," said Simon Chin, founder, president and chief executive officer. "We welcome Doug, John, Frank, and Gayle to our growing team, as we prepare for dynamic growth."

As of January 1, 2015, hospitals, medical clinics, surgery centers, and other medical providers are required by law to have electronic medical records in HL7 format. Unlike the pdf format, HL7 is a friendly format for data extraction into the Iris BioWindows System, which will expedite the process in enabling personalized precision medicine. In this year's State of the Union speech, President Obama announced his "Precision Medicine Initiative," and he is expected to detail the program in his fiscal 2016 budget, to be released on February 2, 2015. The effort is likely to receive support from both parties.

This is an exciting time for personalized precision medicine. During the week of the Annual J. P. Morgan Healthcare Conference in San Francisco, Foundation Medicine shares have more than doubled in value on January 12, 2015, after the news of Roche to acquire approximately fifty-percent of the company for more than $1 billion. On January 7, 2015 at CES 2015, the biggest consumer technology show in the world, the world's first Genome Browser on a Mobile Phone was introduced at AT&T on the Blackberry Passport. In 2009, Iris launched "Health Passport" in our BioWindows 2.0 Informatics System for Personalized and Targeted Medicine.